PLAY PODCASTS
Kuala Lumpur's AI MedTech Gambit: Inside Malaysia's New SaMD Compliance Trap | Pure Global

Kuala Lumpur's AI MedTech Gambit: Inside Malaysia's New SaMD Compliance Trap | Pure Global

ASEAN MedTech Insights · Ran Chen

January 6, 20261m 55s

Audio is streamed directly from the publisher (episodes.captivate.fm) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.

Show Notes

Malaysia has just launched a mandatory new regulatory framework for all AI-powered medical software, effective January 2026. This week, we dissect what this means for MedTech innovators and manufacturers aiming for the ASEAN market. This isn't just a minor policy update; it's a fundamental shift in how digital health products are approved and monitored. We explore the new risk-based classification system, the complex requirements for managing adaptive algorithms, and the stringent new rules on cybersecurity and data privacy that could make or break your product launch. Consider this scenario: a promising health-tech company with a market-ready diagnostic AI is preparing its Malaysian launch. Suddenly, they are confronted with the requirement for a "Predetermined Change Control Plan," a document they have never produced before. Their launch is now stalled, forcing them to reallocate resources and navigate a complex approval process that threatens their funding and first-mover advantage. This is the new challenge many now face. Key Takeaways This Episode: * What are the four new risk classifications for AI medical software in Malaysia, and how do you determine where your product fits? * How can you build a "Predetermined Change Control Plan" that will satisfy regulators? * What are the specific new cybersecurity protocols you must now have in place? * Is Malaysia's new framework a blueprint for the rest of the ASEAN region? * How can this regulatory hurdle be turned into a competitive advantage? * What are the new mandatory post-market surveillance activities for learning algorithms? Navigating these complex, country-specific regulations is what we do best. Pure Global offers end-to-end regulatory consulting for MedTech and IVD companies, using local expertise and advanced AI tools to streamline your market access. Don't let regulatory hurdles block your innovation. Contact us at [email protected] or visit https://pureglobal.com/ to secure your market presence.